Abbott's Xience Prime nets FDA clearance
Cardiovascular Business
Abbott has received FDA approval for the next-generation Xience Prime everolimus-eluting coronary stent system for the treatment of coronary artery disease. Xience Prime uses the same drug and biocompatible polymer as the Xience V everolimus-eluting ...
FDA Approves Abbott's Xience Prime Drug-Eluting StentForbes
Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME™ Drug ...PR Newswire (press release)
FDA Approves Xience Prime StentMedPage Today
TheHeart.Org -Mass Device
all 50 news articles »